Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

Research output: Contribution to journal › Letter › peer-review

29 Scopus citations

Original language	English
Pages (from-to)	E49
Journal	Inflammatory bowel diseases
Volume	23
Issue number	10
DOIs	https://doi.org/10.1097/MIB.0000000000001232
State	Published - Oct 1 2017

Access to Document

@article{3ee783e227704f7297c8e0f4d3a96976,

title = "Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease",

author = "Kayci Huff-Hardy and Mai Bedair and Rebecca Vazquez and Ezra Burstein",

year = "2017",

month = oct,

day = "1",

doi = "10.1097/MIB.0000000000001232",

language = "English",

volume = "23",

pages = "E49",

journal = "Inflammatory bowel diseases",

issn = "1078-0998",

number = "10",

}

TY - JOUR

T1 - Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

AU - Huff-Hardy, Kayci

AU - Bedair, Mai

AU - Vazquez, Rebecca

AU - Burstein, Ezra

PY - 2017/10/1

Y1 - 2017/10/1

UR - https://www.scopus.com/pages/publications/85029750172

U2 - 10.1097/MIB.0000000000001232

DO - 10.1097/MIB.0000000000001232

M3 - Letter

C2 - 28858074

AN - SCOPUS:85029750172

SN - 1078-0998

VL - 23

SP - E49

JO - Inflammatory bowel diseases

JF - Inflammatory bowel diseases

IS - 10

ER -